Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation RJ Berckmans, R Nieuwland, AN Böing, FP Romijn, CE Hack, A Sturk Thrombosis and haemostasis 85 (04), 639-649, 2001 | 859 | 2001 |
Oral contraceptives and the risk of venous thrombosis JP Vandenbroucke, J Rosing, KWM Bloemenkamp, S Middeldorp, ... New England Journal of Medicine 344 (20), 1527-1535, 2001 | 833 | 2001 |
The role of phospholipids and factor Va in the prothrombinase complex. J Rosing, G Tans, JWP Govers-Riemslag, RF Zwaal, HC Hemker Journal of Biological Chemistry 255 (1), 274-283, 1980 | 829 | 1980 |
The role of phospholipid and factor VIIIa in the activation of bovine factor X. G van Dieijen, G Tans, J Rosing, HC Hemker Journal of Biological Chemistry 256 (7), 3433-3442, 1981 | 749 | 1981 |
Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second‐and third‐generation oral contraceptives J Rosing, G Tans, GAF Nicolaes, M Thomassen, R Van Oerle, ... British journal of haematology 97 (1), 233-238, 1997 | 461 | 1997 |
The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of … DE Connor, T Exner, DDF Ma, JE Joseph Thrombosis and haemostasis 103 (05), 1044-1052, 2010 | 398 | 2010 |
Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles G Tans, J Rosing, MC Thomassen, MJ Heeb, RF Zwaal, JH Griffin | 396 | 1991 |
Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor TM Hackeng, KM Seré, G Tans, J Rosing Proceedings of the National Academy of Sciences 103 (9), 3106-3111, 2006 | 363 | 2006 |
The role of activated human platelets in prothrombin and factor X activation J Rosing, JL Van Rijn, EM Bevers, G van Dieijen, P Comfurius, RF Zwaal | 356 | 1985 |
Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study J Rosing, S Middeldorp, J Curvers, MCL GDlig, GAF Nicolaes, ... The Lancet 354 (9195), 2036-2040, 1999 | 345 | 1999 |
Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. MJ Heeb, RM Mesters, G Tans, J Rosing, JH Griffin Journal of Biological Chemistry 268 (4), 2872-2877, 1993 | 307 | 1993 |
An alternating site sequence for oxidative phosphorylation suggested by measurement of substrate binding patterns and exchange reaction inhibitions. C Kayalar, JAN Rosing, PD Boyer Journal of Biological Chemistry 252 (8), 2486-2491, 1977 | 307 | 1977 |
Peptide Bond Cleavages and Loss of Functional Activity during Inactivation of Factor Va and Factor VaR506Q by Activated Protein C (∗) GAF Nicolaes, G Tans, MCLGD Thomassen, HC Hemker, I Pabinger, ... Journal of Biological Chemistry 270 (36), 21158-21166, 1995 | 306 | 1995 |
Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C J Rosing, L Hoekema, GAF Nicolaes, MCLGD Thomassen, HC Hemker, ... Journal of Biological Chemistry 270 (46), 27852-27858, 1995 | 304 | 1995 |
Unraveling the mysteries of phospholipid scrambling PJ Sims, T Wiedmer Thrombosis and haemostasis 86 (07), 266-275, 2001 | 302 | 2001 |
A randomized cross-over study on the effects of levonorgestrel-and desogestrel-containing oral contraceptives on the anticoagulant pathways G Tans, J Curvers, S Middeldorp, MCLGD Thomassen, JCM Meijers, ... Thrombosis and haemostasis 84 (07), 15-21, 2000 | 282 | 2000 |
Coagulation factors and the protein C system as determinants of thrombin generation in a normal population A Dielis, E Castoldi, HMH Spronk, R Van Oerle, K Hamulyak, H Ten Cate, ... Journal of Thrombosis and Haemostasis 6 (1), 125-131, 2008 | 280 | 2008 |
Effects on coagulation of levonorgestrel-and desogestrel-containing low dose oral contraceptives: a cross-over study S Middeldorp, JCM Meijers, AE van den Ende, A van Enk, BN Bouma, ... Thrombosis and haemostasis 84 (07), 4-8, 2000 | 273 | 2000 |
Mechanisms of estrogen-induced venous thromboembolism SN Tchaikovski, J Rosing Thrombosis research 126 (1), 5-11, 2010 | 262 | 2010 |
Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people A Toorians, M Thomassen, S Zweegman, EJP Magdeleyns, G Tans, ... The Journal of Clinical Endocrinology & Metabolism 88 (12), 5723-5729, 2003 | 253 | 2003 |